Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.

ABSTRACT:

SUBMITTER: Maslah N 

PROVIDER: S-EPMC11216995 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature